Clinical Trials

Study Title:
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

For more information about the trial above please contact the study team:

Principal Investigator, Anand Sharma, at sharmaak@musc.edu.

Study Coordinator, Nikki Hill, at hilllau@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina